Active Biotech AB
Research Active Biotech AB (ACTI) on Bullrun: market cap SEK 152.89M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerACTI
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryBiotechnology
- CurrencySEK
- Market capSEK 152.89M
- Financial periodFY2024
- Net income-SEK 39.40M
Valuation Snapshot
latest market cap is SEK 152.89M.
About Active Biotech AB
Active Biotech AB (publ), a biotechnology company, engages in the research, development, production, marketing, and sale of medical, chemical, and biotechnology products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase II clinical trial to treat hematological malignancies; Laquinimod, an immunomodulator for the treatment of severe inflammatory eye diseases, such as non-infectious non anterior uveitis;
Frequently asked questions
What is Active Biotech AB's market cap?
Active Biotech AB's market capitalization is SEK 152.89M.
What does Active Biotech AB do?
Active Biotech AB (publ), a biotechnology company, engages in the research, development, production, marketing, and sale of medical, chemical, and biotechnology products in Sweden.